6,316
Views
3
CrossRef citations to date
0
Altmetric
Brief Report

Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome

, , & ORCID Icon
Article: 2185742 | Received 16 Jan 2023, Accepted 14 Feb 2023, Published online: 05 Mar 2023

References

  • Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23–13.
  • Ortiz-Barahona V, Joshi RS, Esteller M. Use of DNA methylation profiling in translational oncology. Semin Cancer Biol. 2022;83:523–535.
  • Oudelaar AM, Higgs DR. The relationship between genome structure and function. Nat Rev Genet. 2021;22(3):154–168.
  • Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000;343(19):1350–1354.
  • Hardy T, Zeybel M, Day CP, et al. Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease. Gut. 2017;66(7):1321–1328. DOI:10.1136/gutjnl-2016-311526
  • Fenaux P, Mufti GJ, Hellström-Lindberg E, et al. Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia. J Clin Oncol. 2010;28(4):562–569.
  • Kantarjian HM, Thomas XG, Dmoszynska A, et al. Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia. J Clin Oncol. 2012;30(21):2670–2677.
  • Pidsley R, Zotenko E, Peters TJ, et al. Critical evaluation of the illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17(1):208.
  • Merkel A, Esteller M. Experimental and bioinformatic approaches to studying DNA methylation in cancer. Cancers (Basel). 2022;14:2.
  • Sandoval J, Heyn H, Moran S, et al. validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics. 2011;6(6):692–702. DOI:10.4161/epi.6.6.16196
  • Moran S, Arribas C, Esteller M. Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics. 2016;8(3):389–399.
  • Garcia-Prieto CA, Álvarez-Errico D, Musulen E, et al. Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome. Epigenetics. 2022;17(12):1677–1685. DOI:10.1080/15592294.2022.2053816
  • Weisenberger DJ. Characterizing DNA methylation alterations from the cancer genome atlas. J Clin Invest. 2014;124(1):17–23.
  • Sadikovic B, Levy MA, Kerkhof J, et al. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders. Genet Med. 2021;23(6):1065–1074.
  • Li S, Christiansen L, Christensen K, et al. Identification, replication and characterization of epigenetic remodelling in the aging genome: a cross population analysis. Sci Rep. 2017;7(1):8183.
  • Heyn H, Moran S, Hernando-Herraez I, et al. DNA methylation contributes to natural human variation. Genome Res. 2013;23(9):1363–1372.
  • Joshi RS, Rigau M, García-Prieto CA, et al. Look-alike humans identified by facial recognition algorithms show genetic similarities. Cell Rep. 2022;40(8):111257.
  • Nwanaji-Enwerem JC, Colicino E. DNA methylation-based biomarkers of environmental exposures for human population studies. Curr Environ Health Rep. 2020;7(2):121–128.
  • Benetatos L, Vartholomatos G. Enhancer DNA methylation in acute myeloid leukemia and myelodysplastic syndromes. Cell Mol Life Sci. 2018;75(11):1999–2009.
  • Heyn H, Vidal E, Ferreira HJ, et al. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer. Genome Biol. 2016;17(1):11. DOI:10.1186/s13059-016-0879-2
  • Achour M, le Gras S, Keime C, et al. Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of huntington’s disease mice. Hum Mol Genet. 2015;24(12):3481–3496.
  • Juraeva D, Haenisch B, Zapatka M, et al. Integrated pathway-based approach identifies association between genomic regions at CTCF and CACNB2 and schizophrenia. PLoS Genet. 2014;10(6):e1004345.
  • Dunham I, Kundaje A, Aldred SF, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57–74.
  • Moore JE, Purcaro MJ, Pratt HE, et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature. 2020;583(7818):699–710.
  • Lizio M, Harshbarger J, Shimoji H, et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol. 2015;16(1):22.
  • Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of infinium DNA methylation beadchip probes. Nucleic Acids Res. 2017;45(4):e22.
  • Kundaje A, Meuleman W, Ernst J, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317–330. DOI:10.1038/nature14248
  • Moran S, Vizoso M, Martinez-Cardús A, et al. Validation of DNA methylation profiling in formalin-fixed paraffin-embedded samples using the infinium HumanMethylation450 microarray. Epigenetics. 2014;9(6):829–833. DOI:10.4161/epi.28790
  • Wang J, Zhuang J, Iyer S, et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res. 2012;22(9):1798–1812.
  • Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25–29.